Ovarian Clear Cell Carcinoma Presented as Rapidly Progression of Abdominal Mass in a Postmenopausal Woman: A Case Report

In: Research Journal of Pharmacy and Technology · 2026 · vol. 19(4) , pp. 1849 · doi:10.52711/0974-360x.2026.00265 · W7154570591
article OA: closed CC0
Full text JSON View on OpenAlex View at publisher

Abstract

Ovarian clear cell carcinoma (OCCC) is a distinct and relatively uncommon subtype of epithelial ovarian cancer, characterised by unique histopathological features, molecular alterations, and clinical behaviour. It is often associated with endometriosis and demonstrates relative resistance to conventional platinum-based chemotherapy. We report the case of a 60-year-old nulliparous postmenopausal woman who presented with a rapidly enlarging abdominal mass, weight loss, and pressure symptoms over three months. Imaging revealed a large right adnexal solid-cystic mass suggestive of ovarian malignancy with concomitant uterine fibroids. Tumour markers were elevated, particularly CA 125 and CA 19-9. She underwent definitive surgical management, including total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and appendicectomy. Histopathological examination confirmed ovarian clear cell carcinoma, FIGO stage IC. She subsequently commenced adjuvant chemotherapy. This case highlights the aggressive clinical presentation of OCCC in a postmenopausal woman and underscores the importance of early recognition, comprehensive surgical staging, and histopathological diagnosis. OCCC remains a therapeutic challenge due to its chemoresistant nature, necessitating ongoing research into targeted therapies.
Full text 4,097 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Ovarian clear cell carcinoma (OCCC) is a distinct and relatively uncommon subtype of epithelial ovarian cancer, characterised by unique histopathological features, molecular alterations, and clinical behaviour. It is often associated with endometriosis and demonstrates relative resistance to conventional platinum-based chemotherapy. We report the case of a 60-year-old nulliparous postmenopausal woman who presented with a rapidly enlarging abdominal mass, weight loss, and pressure symptoms over three months. Imaging revealed a large right adnexal solid-cystic mass suggestive of ovarian malignancy with concomitant uterine fibroids. Tumour markers were elevated, particularly CA 125 and CA 19-9. She underwent definitive surgical management, including total abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and appendicectomy. Histopathological examination confirmed ovarian clear cell carcinoma, FIGO stage IC. She subsequently commenced adjuvant chemotherapy. This case highlights the aggressive clinical presentation of OCCC in a postmenopausal woman and underscores the importance of early recognition, comprehensive surgical staging, and histopathological diagnosis. OCCC remains a therapeutic challenge due to its chemoresistant nature, necessitating ongoing research into targeted therapies. Cite this article: Soe Lwin, Syed Rahim Syed Hamid, Malhi Fatehpal Singh, Aruku Naidu, Tin Moe Nwe, Khin Than Yee, Myat San Yi, Swe Swe Latt. Ovarian Clear Cell Carcinoma Presented as Rapidly Progression of Abdominal Mass in a Postmenopausal Woman: A Case Report. Research Journal of Pharmacy and Technology. 2026;19(4):1849-1. doi: 10.52711/0974-360X.2026.00265 Cite(Electronic): Soe Lwin, Syed Rahim Syed Hamid, Malhi Fatehpal Singh, Aruku Naidu, Tin Moe Nwe, Khin Than Yee, Myat San Yi, Swe Swe Latt. Ovarian Clear Cell Carcinoma Presented as Rapidly Progression of Abdominal Mass in a Postmenopausal Woman: A Case Report. Research Journal of Pharmacy and Technology. 2026;19(4):1849-1. doi: 10.52711/0974-360X.2026.00265 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2026-19-4-54

References

1. Chang TY, Yeh CY, Yang CY, et al. Ovarian clear cell carcinoma with uterine intramural recurrence: case report of ovarian clear cell carcinoma with fertility sparing treatment. Taiwanese Journal of Obstetrics and Gynecology. 2024; 63(1):90–94. 2. El Hachami FZ, Sabiri R, Imami Y, et al. Clear Cell Carcinoma of the Ovary: A Case Report. Am J Surg Case Rep. 2024; 5(1): 1113. 3. Iida Y, Okamoto A, Hollis RL, Gourley C, Herrington CS. Clear cell carcinoma of the ovary: a clinical and molecular perspective. Int J Gynecol Cancer. 2021; 31(4):605–616. 4. Pence S, Rath K, Clements A. Treatment of Ovarian Clear Cell Carcinoma: A Case of Successful Management with Targeted Therapies. Case Rep Obstet Gynecol. 2025; 2025: 1319978. 5. Rahul K, Ranjith S, Muralee M, et al. Clear Cell Carcinoma of the Ovary with Isolated Contiguous Hepatopulmonary Metastasis. Indian J Gynecol Oncol. 2024; 22(3): 102. 6. Yin D, Jiang YJ. Case Series and a Literature Review: Two Ovarian Clear Cell Carcinoma Cases with Recurrent Endometriosis. Int J Womens Health. 2023: 1611–1619. Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>> RNI: CHHENG00387/33/1/2008-TCDOI: 10.52711/0974-360X 1.3 2021CiteScore 56th percentile Powered by

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

References (5)

Source provenance

openalex
last seen: 2026-07-03T06:05:06.779468+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK